about
Statins for children with familial hypercholesterolemiaToxicologic lesions associated with two related inhibitors of oxidosqualene cyclase in the dog and mouseLanosterol synthase mutations cause cholesterol deficiency-associated cataracts in the Shumiya cataract ratLipids and the ocular lensLight-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.Retinal structure and function in an animal model that replicates the biochemical hallmarks of desmosterolosisCongenital cataract and multisystem disorders.Structural and functional changes in the alpha A-crystallin R116C mutant in hereditary cataracts.Properties of membranes derived from the total lipids extracted from clear and cataractous lenses of 61-70-year-old human donorsSynthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol.Novel splice-affecting variants in CYP27A1 gene in two Chilean patients with Cerebrotendinous XanthomatosisBilateral cataract in a cynomolgus monkey.A spontaneous mutation in Srebf2 leads to cataracts and persistent skin wounds in the lens opacity 13 (lop13) mouse.Functions of cholesterol and the cholesterol bilayer domain specific to the fiber-cell plasma membrane of the eye lens.The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.Statin Use and Incident Cataract Surgery: A Case-Control Study.Etiopathogenesis of cataract: an appraisal.The controversy of a wider statin utilization: why?Statin treatment, new-onset diabetes, and other adverse effects: a systematic review.Statins for children with familial hypercholesterolemia.Organization of lipids in fiber-cell plasma membranes of the eye lens.Characterization of the ordered phase formed by sphingomyelin analogues and cholesterol binary mixtures.Cholesterol in bilayers of sphingomyelin or dihydrosphingomyelin at concentrations found in ocular lens membranes.Ophthalmic diseases and disorders in free-ranging rhesus macaque (Macaca mulatta) of Shivalik hill area of Himachal Pradesh, Northern India.Contribution of cholesterol and oxysterols in the physiopathology of cataract: implication for the development of pharmacological treatmentsAssociation of angiotensin-converting enzyme, CYP46A1 genes polymorphism with senile cataract.E2012-induced cataract and its predictive biomarkers.Quantification of dolichol in the human lens with different types of cataracts.Evidence for distinct cholesterol domains in fiber cell membranes from cataractous human lenses.Statin use and cataract surgery: a nationwide retrospective cohort study in elderly ethnic Chinese patients.Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor.The Doyne Lecture. Congenital cataract: the history, the nature and the practice.Probing cataractogenesis associated with mevalonic aciduria.Cholesterol may act as an antioxidant in lens membranes
P2860
Q24194816-525906E6-84A6-4A5F-946D-1AB45BB8D1A7Q28203261-716C38EC-65BD-466E-81EC-17F1D98A0876Q28566325-607FF16A-2DCE-49C4-B04C-53E392D5097BQ28749880-A3E0B49C-4F47-4EB5-BD72-70C33EF220DEQ33750546-034817F2-F1AA-4071-AF64-3D491410D3DFQ33751200-38AFB14F-0DFA-497A-9625-B17EBF9065C3Q33812626-6ECC95BE-A0FD-4FDF-A182-DF224C17F951Q33989123-477D01B1-A42F-409B-8798-6B9E72FA2D81Q35070254-76AC5F3D-C5FA-474F-A81F-4EF547C50E20Q35185212-D6F44B5F-BBA4-418A-ACCA-5B3296A65A27Q35556926-32FDC1B9-6E1F-46AF-A26B-3914C70D608DQ35603958-E0F91E85-EE17-47BC-9FC2-37A1137C8989Q35654048-CB8CFE61-ACCA-4CE4-BA1B-14DE98624A77Q35785790-F9041985-B5FD-4B71-86E5-5D00B3BE8384Q35927194-DBB5F747-1269-4264-A7A9-7A7282EB1BCDQ37432533-5EC7995B-53CF-47FE-A5D9-FE4414A65DF9Q37733413-3A8DC869-9597-4EA7-B6B6-0621EB9BCB95Q38089090-1F35542D-B2BA-4AF9-9EB8-5735BE8C7454Q38181977-B06D6D3D-9145-449C-9290-A6153E7AA392Q38689931-A35C004A-B8BF-438B-BAFA-539832190A0CQ38779059-941824DC-1E1A-40F8-A1EC-B5E20E427A88Q39521730-1A29A1D9-05BD-4457-8E9F-652032EFBD8BQ40235761-B13F51F9-81C0-441F-81C1-A8A2D4E63A88Q40255354-CD6B558F-0DF7-44E5-AF03-C809A228FE8EQ41879279-11CCEE61-2A17-4A2A-9BDC-29BE600C3480Q42318199-AD4BC708-AEEB-4F15-9F59-3D8638749497Q42709121-8D190003-1D33-4992-AA12-2FB2C9782478Q43067667-3E520B27-FBCA-4181-8BDC-F649F8B26D19Q43559692-93ABD62F-9822-4E9A-90AF-192AE497510EQ43988843-F2FEC292-94C7-45D0-88CA-D704B20E2542Q44854860-0C8E22DC-8981-4CCC-93FD-A76A7390ECA1Q48499806-1E70B9AA-F04B-4287-AA00-EC2BDA1C2EBEQ52189465-A494899D-BE6C-4A60-A691-A639B8520DD9Q57843434-26F9D691-7568-46AA-B0C7-414CD6528039
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Cholesterol and cataracts.
@en
type
label
Cholesterol and cataracts.
@en
prefLabel
Cholesterol and cataracts.
@en
P1476
Cholesterol and cataracts.
@en
P2093
Cenedella RJ
P304
P356
10.1016/S0039-6257(96)82007-8
P577
1996-01-01T00:00:00Z